valine has been researched along with HIV Coinfection in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 53 (30.11) | 18.2507 |
| 2000's | 38 (21.59) | 29.6817 |
| 2010's | 77 (43.75) | 24.3611 |
| 2020's | 8 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Agrati, C; Ammassari, A; Antinori, A; Bellagamba, R; Cicalini, S; Fabbri, G; Grilli, E; Lorenzini, P; Mastrorosa, I; Notari, S; Tempestilli, M; Vergori, A | 1 |
| Cecka, F; Cerveny, L; Huliciak, M; Martinec, O; Staud, F; Vokral, I | 1 |
| Ahumada, A; Aldamiz-Echevarría, T; Baliellas, C; Barril, G; Benlloch, S; Bonet, L; Carmona, I; Castaño, MA; Castro, Á; de Álvaro, C; de Los Santos, I; Delgado, M; Devesa-Medina, MJ; García-Buey, L; García-Samaniego, J; Gea-Rodríguez, F; González-Parra, E; Gutiérrez, ML; Jiménez-Pérez, M; Laguno, M; Londoño, MC; Losa, JE; Mallolas, J; Manzanares, A; Martín-Granizo, I; Montero-Alonso, M; Montes, ML; Morán-Sánchez, S; Morano, L; Muñoz-Gómez, R; Navascués, CA; Polo-Lorduy, B; Riveiro-Barciela, M; Rivero, A; Roget, M; Serra, MÁ | 1 |
| Aguilar, P; Aldámiz-Echevarría, T; Andrade, RJ; Carnicer, F; Carrión, JA; Chimeno-Hernández, S; Delgado, M; Escarda, A; Espinosa, N; Estébanez, Á; Gallego, A; García-Buey, L; Hernández-Guerra, M; Hijona, L; Izquierdo, S; Jou, A; Lorente, S; Magaz, M; Manuel Sousa, J; Manzanares, A; Martín-Granizo, I; Mateos-Muñoz, B; Menéndez, F; Morán-Sánchez, S; Morano, L; Moreno-Planas, JM; Morillas, RM; Polo-Lorduy, B; Pulido, F; Rico, M; Rincón, D; Rodríguez, M; Rubín, Á; Salmerón, J; Sampedro, B; Sánchez Antolín, G; Vergara, M; Von-Wichmann, MÁ; Zozaya, JM | 1 |
| Abdel Alem, S; Abdel Aziz, H; Abdellatif, Z; Al Askalany, M; Cordie, A; El Akel, W; Elsharkawy, A; Esmat, G; Kamal, W; Kamel, S; Kandeel, A; Meshaal, S | 1 |
| Bonora, S; Cingolani, A; d'Arminio Monforte, A; Lo Caputo, S; Marinaro, L; Mussini, C; Puoti, M; Rossotti, R; Saracino, A; Soria, A; Tavelli, A; Uberti-Foppa, C | 1 |
| Alston-Smith, BL; Anthony, DD; Balagopal, A; Bhattacharya, D; Cohen, DE; Damjanovska, S; Kowal, CM; Shive, CL; Smeaton, LM; Sulkowski, MS; Wyles, DL | 1 |
| Aho, I; Amele, S; Bhagani, S; Chkhartisvili, N; Clarke, A; Domingo, P; Falconer, K; Fonquernie, L; Jabłonowska, E; Leen, C; Lundgren, J; Maltez, F; Matulionyte, R; Mocroft, A; Peters, L; Rockstroh, J; Rodger, A; Sarcletti, M; Stephan, C; Szlavik, J; Wandeler, G; Zaccarelli, M; Østergaard, L | 1 |
| Andrieux-Meyer, I; Avihingsanon, A; Bompart, F; Chan, WK; Cressey, TR; Goyal, V; Hassan, MRA; Khemnark, S; Kumar, S; Menétrey, C; Murad, S; Ngo-Giang-Huong, N; Omar, H; Pécoul, B; Said, HRHM; Salvadori, N; Simon, F; Siva, S; Swanson, A; Tan, SS; Tee, HP; Thanprasertsuk, S; Thetket, K; Thongsawat, S; Yerly, S | 1 |
| Dehghan Manshadi, SA; Kalantari, S; Karimi, J; Malekzadeh, R; Malekzadeh, Z; Mardani, M; Merat, D; Merat, S; Mirminachi, B; Mohraz, M; Nikbin, M; Norouzi, A; Poustchi, H; Rasoolinejad, M; Sali, S; Sedghi, R; Sharifi, AH; Somi, MH; Tabarsi, P; Tayeri, K | 1 |
| Amelia, F; Hapsari, AI; Karjadi, TH; Natali, V; Sulaiman, AS; Wicaksana, B; Widhani, A; Yunihastuti, E | 1 |
| Bregigeon, S; Colson, P; Dhiver, C; Lacarelle, B; Menard, A; Poizot-Martin, I; Ravaux, I; Ressiot, E; Ruiz, JM; Solas, C; Taton, A; Tomei, C | 1 |
| Falhas, C; Henrique, M; Kieselova, K; Santiago, F | 1 |
| Aoki, T; Gatanaga, H; Kikuchi, Y; Kinai, E; Mizokami, M; Mizushima, D; Oka, S; Sugiyama, M; Teruya, K; Tsukada, K; Uemura, H; Watanabe, K | 1 |
| Agrati, C; Ammassari, A; Antinori, A; Bellagamba, R; Fabbri, G; Libertone, R; Lupi, F; Mastrorosa, I; Notari, S; Tempestilli, M; Timelli, L; Zaccarelli, M | 1 |
| Komatsu, H; Miyata, N; Tachikawa, N; Yoshimura, Y | 1 |
| Agrati, C; Ammassari, A; Antinori, A; Fabbri, G; Libertone, R; Notari, S; Tempestilli, M | 1 |
| Collado, A; de Los Santos, I; Macías, J; Mancebo, M; Merino, D; Morano-Amado, LE; Palacios, R; Pérez, AB; Pérez-Pérez, M; Pineda, JA; Ríos, MJ; Rivero, A; Rivero-Juárez, A; Téllez, F | 1 |
| Fan, H; Fu, Z; Huang, P; Tian, T; Wang, Y; Wu, J; Xia, X; Ye, X; Yue, M; Zhang, Y | 1 |
| Clement, ME; Craig, DM; Ilkayeva, O; Muehlbauer, MJ; Naggie, S; Okeke, NL; Shah, SH | 1 |
| Atkinson, JH; Bush, WS; Ellis, RJ; Franklin, D; Keltner, J; Letendre, S; Umlauf, A; Xu, J | 1 |
| Chen, J; Li, J; Lu, H; Wang, J; Xiao, H; Yang, F | 1 |
| Barrail-Tran, A; Botta-Fridlund, D; Cagnot, C; Canva, V; Coilly, A; Conti, F; D'Alteroche, L; Danjou, H; De Ledinghen, V; Duclos-Vallée, JC; Durand, F; Duvoux, C; Fougerou-Leurent, C; Gelé, T; Goldwirt, L; Houssel-Debry, P; Kamar, N; Laforest, C; Lavenu, A; Leroy, V; Moreno, C; Pageaux, GP; Radenne, S; Samuel, D; Taburet, AM | 1 |
| Bolon, DNA; Henes, M; Kosovrasti, K; Kurt Yilmaz, N; Leidner, F; Lockbaum, GJ; Nachum, GS; Nalivaika, EA; Schiffer, CA; Whitfield, TW | 1 |
| Baeten, JM; Corey, L; Diem, K; Huang, ML; Johnston, C; Magaret, A; Ocbamichael, N; Perti, T; Saracino, M; Selke, S; Wald, A | 1 |
| Kain, KC; Kaul, R; Kumar, S; Raboud, J; Rajwans, N; Shannon, B; Szadkowski, L; Tan, DH; Walmsley, S; Yi, TJ | 1 |
| Bertz, R; Bifano, M; Grasela, D; Hartstra, J; Hwang, C; Kandoussi, H; Oosterhuis, B; Sevinsky, H; Tiessen, R; Velinova-Donga, M | 1 |
| Dieterich, DT; Martel-Laferrière, V | 1 |
| Abu-Raddad, LJ; Awad, SF; Cuadros, DF; García-Ramos, G | 1 |
| Bachmann, LH; Geisler, WM; Hook, EW; Van Wagoner, N | 1 |
| Bassit, LC; Grivel, JC; Kauffman, RC; Lederman, MM; Lisco, A; Margolis, L; Rodriguez, B; Sanchez, J; Schinazi, RF; Vanpouille, C | 1 |
| Hayward, P | 1 |
| Aboulker, JP; Bailly, F; Billaud, E; Bronowicki, JP; Diallo, A; Izopet, J; Lacombe, K; Meyer, L; Molina, JM; Paniez, H; Piroth, L; Rey, D; Rosenthal, E; Simony, M; Taburet, AM; Vincent, C; Zucman, D | 1 |
| Stingl, W | 1 |
| Deeks, ED | 1 |
| Ackerman, P; Dieterich, D; Dretler, R; Fishbein, D; Gathe, JC; Henn, S; Hinestrosa, F; Hughes, E; Huynh, C; Liu, Z; Luetkemeyer, A; McDonald, C; McPhee, F; Mills, A; Morgan, TR; Noviello, S; Overton, ET; Ramgopal, M; Rashbaum, B; Ray, G; Ruane, PJ; Scarsella, A; Sherman, KE; Sulkowski, MS; Wyles, DL; Yin, PD; Yozviak, J | 1 |
| Cattaneo, D; Charbe, N; Clementi, E; Gervasoni, C; Resnati, C; Sollima, S | 1 |
| Barrail-Tran, A; Cheret, A; Furlan, V; Molina, JM; Piroth, L; Rosa, I; Rosenthal, E; Taburet, AM; Vincent, C | 1 |
| Antinori, S; Calvi, E; Milazzo, L; Regalia, E; Sollima, S; Torre, A | 1 |
| Busuttil, RW; Cheng, EY; Holt, CD; Saab, S | 1 |
| Awni, W; Dutta, S; Khatri, A; Menon, R; Podsadecki, T; Trinh, R; Wang, H | 1 |
| Aichelburg, MC; Bucsics, T; Chromy, D; Grabmeier-Pfistershammer, K; Mandorfer, M; Peck-Radosavljevic, M; Reiberger, T; Scheiner, B; Schwabl, P; Stättermayer, AF; Steiner, S; Trauner, M | 1 |
| Ackerman, P; Kalsekar, A; Kelley, C; Mu, F; Peeples, M; Signorovitch, J; Song, J; Swallow, E; Yuan, Y | 1 |
| Cattaneo, D; Clementi, E; Gervasoni, C; Milazzo, L; Riva, A | 1 |
| Benhaourech, S; Borentain, P; Bregigeon, S; Colson, P; Darque, A; Gaubert, MR; Habib, G; Laugier, D; Maille, B; Renard, S; Salaun, E | 1 |
| Ackens, R; Posthouwer, D | 1 |
| Ackerman, P; Bhore, R; Luetkemeyer, AF; McDonald, C; Noviello, S; Ramgopal, M | 1 |
| Baños, I; Bellot, P; Bhamidimarri, KR; Brainard, DM; Campos-Varela, I; Castells, L; Grewal, P; Guaraldi, G; Hasson, H; McHutchison, JG; Morbey, A; Moreno, A; Terrault, NA | 1 |
| Cattaneo, D; D'Avolio, A; Gervasoni, C; Micheli, V; Milazzo, L; Sollima, S | 1 |
| Burger, DM; D'Avolio, A; Di Perri, G; Drenth, JP; Grintjes, K; Kanter, CT; Smolders, EJ; van Crevel, R | 1 |
| Gschwantler, M; Haltmayer, H; Marchart, K; Moser, S; Schìtz, A | 1 |
| Neumaier, J | 1 |
| Gonzalez, YS; Johnson, S; Juday, T; Misurski, D; Parisé, H; Saab, S; Virabhak, S; Wang, A | 1 |
| Andreis, S; Basso, M; Cattelan, AM; Cavinato, S; Dal Bello, F; Loregian, A; Messa, L; Nannetti, G; Palù, G; Parisi, SG; Scaggiante, R | 1 |
| Aichelburg, MC; Bucsics, T; Chromy, D; Grabmeier-Pfistershammer, K; Mandorfer, M; Peck-Radosavljevic, M; Reiberger, T; Scheiner, B; Schwabl, P; Steiner, S; Trauner, M | 1 |
| Khatri, A; Menon, R; Podsadecki, T; Trinh, R; Zhao, W | 1 |
| Hirashima, N; Ikeda, H; Imamura, J; Itoh, F; Iwase, H; Matsumoto, N; Okuse, C; Ryuge, N; Shimada, M; Tanaka, Y; Watanabe, T; Yokomaku, Y | 1 |
| Burger, DM; Colbers, EP; de Kanter, CT; Drenth, JP; Smolders, EJ; Velthoven-Graafland, K | 1 |
| Adams, D; Andersen-Nissen, E; Baeten, JM; Celum, C; Chang, JT; Coombs, RW; McElrath, MJ; Sanchez, J; Thomas, KK | 1 |
| Ingiliz, P; Jimenez-Exposito, MJ; Peck-Radosavljevic, M; Petersen, J; Rockstroh, JK; Van der Valk, M; Welzel, TM; Zeuzem, S; Zhao, Y | 1 |
| But, DY; Chan, CK; Chan, HL; Chan, KH; Fung, J; Hui, YT; Lai, CL; Lai, MS; Lam, YS; Lao, WC; Li, C; Lui, GC; Seto, WK; Tsang, OT; Wong, GL; Wong, VW; Yuen, MF | 1 |
| Flisiak, R; Flisiak-Jackiewicz, M; Pogorzelska, J | 1 |
| Backus, LI; Belperio, PS; Bhattacharya, D; Goetz, MB; Loomis, TP; Mole, LA; Shahoumian, TA | 1 |
| Ackerman, P; Berenguer, J; Cheinquer, H; Côté, P; Dieterich, D; Eley, T; Fessel, WJ; Gadano, A; Hernandez, D; Hughes, E; Lazzarin, A; Liu, Z; Matthews, G; McPhee, F; Mendez, P; Molina, JM; Moreno, C; Noviello, S; Pineda, JA; Pulido, F; Rivero, A; Rockstroh, J; Sulkowski, MS; Zakharova, N | 1 |
| Sharma, DP; Singh, J; Sinha, S; Tandon, S | 1 |
| King, JR; Menon, RM | 1 |
| Akremi, R; Allegre, T; Antonini, T; Aumaitre, H; Batisse, D; Bennai, Y; Billaud, E; Chas, J; Dabis, F; De Ledinghen, V; De Truchis, P; Dhiver, C; Dominguez, S; Fedchuk, L; Filipovics, A; Fontaine, H; Harent, S; Lacombe, K; Lafeuillade, A; Leroy, V; Metivier, S; Miailhes, P; Pageaux, GP; Perre, P; Rosenthal, E; Salmon Ceron, D; Sogni, P; Valantin, MA; Zhao, Y | 1 |
| Conway, B; Lazzarin, A; Luetkemeyer, A; Molina, JM; Nelson, M; Portsmouth, S; Romanova, S; Rubio, R; Srinivasan, S; Xu, D | 1 |
| Casari, S; Castelli, F; Festa, E; Izzo, I; Lanza, P; Odolini, S; Vavassori, A; Zaltron, S | 1 |
| Baeten, JM; Celum, C; Coombs, RW; Corey, L; Lucchetti, A; Magaret, A; Sanchez, J; Strick, LB; Wald, A; Whittington, WL | 1 |
| Celum, C; Coombs, RW; Corey, L; Lucchetti, A; Magaret, A; Sánchez, J; Wald, A; Whittington, WL; Zuckerman, RA | 1 |
| Albuquerque, MG; Ceva Antunes, OA; da Cunha, EF; de Alencastro, RB; de Castro Ramalho, T; Sippl, W | 1 |
| Lisco, A; Margolis, L; Vanpouille, C | 1 |
| Frank, I; Robbiani, M | 1 |
| Cahn, P; Grinsztejn, B; Kaul, R; Raboud, JM; Tan, DH; Walmsley, SL | 1 |
| Baeten, JM; Beck, I; Celum, C; Corey, L; Essex, M; Farquhar, C; Fife, KH; Frenkel, LM; Kiarie, J; Lingappa, J; Makhema, J; Mugo, N; Pepper, G; Sanchez, J; Wald, A; Were, E | 1 |
| Razonable, RR | 1 |
| Abu-Raddad, LJ; Tanton, C; Weiss, HA | 1 |
| Baeten, JM; Celum, C; Irungu, E; Mugo, NR; Mugwanya, K; Ngure, K | 1 |
| Drake, AL; Emery, S; Farquhar, C; Hitti, J; John-Stewart, G; Kiarie, J; Ongecha-Owuor, F; Overbaugh, J; Richardson, BA; Roxby, AC; Wald, A | 1 |
| Boyd, P; Doyle, LA; Fetherston, SM; Geer, L; Goldman, L; Ketas, TJ; Klasse, PJ; Lowry, D; Major, I; Malcolm, RK; Moore, JP; Murphy, DJ; Rasmussen, KK; Shattock, RJ; Veazey, RS | 1 |
| Adekunle, V; Akolawole, M; Obiako, R; Ogoina, D; Ovosi, J; Umar, A | 1 |
| Barreiro, P; del Mar Gonzalez, M; Plaza, Z; Poveda, E; Seclén, E; Soriano, V; Vispo, E | 1 |
| Banzola, N; Bellavista, S; D'Antuono, A; Gaspari, V; Patrizi, A | 1 |
| Drake, AL; Farquhar, C; John-Stewart, G; Kiarie, J; Richardson, BA; Roxby, AC; Wald, A | 1 |
| Arien, KK; Fackler, OT; Geyer, M; Iannucci, V; Meuwissen, PJ; Naessens, E; Saksela, K; Stolp, B; Vanham, G; Verhasselt, B; Vermeire, J | 1 |
| Shah, I | 1 |
| Drake, AL; Emery, S; Farquhar, C; John-Stewart, GC; Kiarie, JN; Matemo, DN; Ongecha-Owuor, F; Overbaugh, J; Richardson, B; Roxby, AC; Wald, A | 1 |
| De Rosa, S; Drake, AL; Farquhar, C; John-Stewart, GC; Kiarie, JN; Liu, AY; Lohman-Payne, BL; Richardson, B; Roxby, AC; Wald, A | 1 |
| Grimwood, A; Hayes, VM; Laten, A; Petersen, DC; Rensburg, EJ; Zeier, MD | 1 |
| Corey, L | 1 |
| Baker, D; Snowden, W; Tyring, SK | 1 |
| Patel, R | 1 |
| Cohen, J | 1 |
| Berzofsky, JA; Lemonnier, F; Okazaki, T; Pendleton, CD | 1 |
| Flaitz, CM; Nichols, CM; Walling, DM | 1 |
| Feinberg, J; Jacobson, DL; Wu, AW | 1 |
| Brennan, CA; DeJesus, E; Hill, JL; Schacker, TW; Shahmanesh, M; Trottier, S; Wald, A; Warren, T | 1 |
| Crumpacker, CS | 1 |
| Flaitz, CM; Hosein, FG; Montes-Walters, M; Nichols, CM; Walling, DM | 1 |
| Etienne, W; Flaitz, CM; Nichols, CM; Ray, AJ; Walling, DM | 1 |
| Flaitz, CM; Gordadze, AV; Ling, PD; Montes-Walters, M; Nichols, CM; Walling, DM | 1 |
| Dufour, J; Klasse, PJ; Kunstman, KJ; Marozsan, AJ; Moore, JP; Springer, MS; Veazey, RS; Wolinsky, SM | 1 |
| Bartlett, JG | 1 |
| Brennan, CA; Harris, J; Warren, T | 1 |
| Colonno, RJ; Dufour, J; Hu, Q; Ketas, TJ; Klasse, PJ; Lu, M; Marx, PA; Moore, JP; Schader, SM; Shattock, RJ; Springer, MS; Veazey, RS | 1 |
| Towie, N | 1 |
| Andonaba, JB; Defer, MC; Foulongne, V; Konate, I; Mayaud, P; Nagot, N; Ouedraogo, A; Sanon, A; Segondy, M; Van de Perre, P; Vergne, L; Weiss, HA | 1 |
| Andonaba, JB; Becquart, P; Defer, MC; Djagbaré, D; Foulongne, V; Konaté, I; Mayaud, P; Nagot, N; Ouédraogo, A; Sanon, A; Sawadogo, A; Segondy, M; Vallo, R; Van de Perre, P; Vergne, L; Weiss, HA | 1 |
| Boothby, M; Radcliffe, K | 1 |
| Wilkinson, E | 1 |
| Ketas, TJ; Klasse, PJ; Lu, M; Moore, JP; Polonis, V; Schader, SM; Teo, E; Zurita, J | 1 |
| Antinori, A; Bertoli, A; Ceccherini-Silberstein, F; Forbici, F; Liuzzi, G; Lorenzini, P; Marconi, P; Mosti, S; Narciso, P; Perno, CF; Tozzi, V; Trotta, MP; Zaccarelli, M | 1 |
| Dauer, B; Doerr, HW; Haberl, A; Hanke, N; Knecht, G; Locher, L; Moesch, M; Mueller, A; Staszewski, S; Stürmer, M | 1 |
| Caumes, E; Martinez, V | 1 |
| Eisenhut, M | 1 |
| Ayala, JM; Azimzadeh, AM; DeMartino, JA; Iliff, S; Kawka, DW; Lu, M; Lyons, K; Miller, GG; Mills, SG; Mudgett, JS; Nguyen, BN; Peterson, LB; Pierson, RN; Schröder, C; Siciliano, SJ; Singer, II; Springer, MS; Wu, G; Zhang, T | 1 |
| Celum, C; Coombs, RW; Corey, L; Lucchetti, A; Magaret, AS; Sanchez, J; Wald, A; Whittington, WL; Zuckerman, RA; Zuñiga, R | 1 |
| Gozlan, M | 1 |
| Bouza, E; Carr, A; Danner, SA; Gonzales, J; Gudiol, F; Lehman, LM; Leonard, JM; Pintado, V; Raventos, A; Rubio, R | 1 |
| Henry, D; Hsu, A; Hurley, AM; La Marca, A; Leonard, JM; Markowitz, M; Powderly, WG; Saag, M; Sattler, F; Valdes, JM | 1 |
| Boucher, CA; Granneman, R; Ho, DD; Hsu, A; Jurriaans, S; Reedijk, M; Sereni, D; Tzeng, TB; van Bommel, T; Veyssier, P | 1 |
| Blum, MR; Coakley, D; Feinberg, J; Gallant, J; Gary, D; Jacobson, MA; Smiley, ML; Squires, L; Wang, LH; Weller, S | 1 |
| Erickson, J; Hoekzema, DT; Kageyama, S; Kempf, DJ; Kojima, E; Mitsuya, H; Murakawa, Y; Norbeck, DW; Shirasaka, T | 1 |
| Carr, A; Cooper, DA; Kelleher, AD; Zaunders, J | 1 |
| Cimons, M | 1 |
| Nelson, H | 1 |
| Ho, DD; Leonard, JM; Markowitz, M; Neumann, AU; Perelson, AS | 1 |
| Nathan, R | 1 |
| Boucher, CA; Chernyavskiy, T; Gao, Q; Granneman, GR; Ho, DD; Hsu, A; Kempf, DJ; Korneyeva, M; Leonard, JM; Lyons, N; Markowitz, M; Mo, HM; Molla, A; Niu, P; Norbeck, DW; Schipper, PJ; Vasavanonda, S | 1 |
| Blum, MR; Millard, J; Painter, G; Parry, N; Rooney, J; Sadler, BM; St Clair, MH; Tisdale, M | 1 |
| Bilello, JA; Bilello, PA; Drusano, GL; Prichard, M | 1 |
| Schenk, M | 1 |
| Amado, RG; Chen, IS; Jamieson, BD; Kaplan, AH; Koka, PS; Withers-Ward, ES; Zack, JA | 1 |
| Bell, WR; Chulay, JD; Feinberg, JE | 1 |
| Bloor, S; de Béthune, MP; Gröschel, B; Harrigan, PR; Hertogs, K; Kemp, SD; Larder, BA; Miller, V; Pauwels, R; Staszewski, S; Stürmer, M | 1 |
| Cammack, N; Chirn, GW; Craig, C; Dissanayeke, S; Duncan, IB; Gilbert, S; Moffatt, A; Race, E; Rose, J; Sheldon, J; Whittaker, L | 1 |
| Phillips, L | 1 |
| Emery, VC; Feinberg, JE; Griffiths, PD; Grywacz, M; Knight, S; Sabin, C | 1 |
| de Ana, AM; Martínez-A, C; Mellado, M; Rodríguez-Frade, JM; Vila-Coro, AJ | 1 |
| Bui, DT; Duong, CT; Hoang, TL; Kato, K; Kusagawa, S; Motomura, K; Nagai, Y; Nguyen, TH; Nohtomi, K; Pham, HT; Pham, KC; Sato, H; Shibamura, K; Shiino, T; Takebe, Y; Yang, R | 1 |
| Agut, H; Angleraud, F; Calvez, V; Delaugerre, C; Huraux, JM; Katlama, C; Mouroux, M; Simon, A; Yvon-Groussin, A | 1 |
| Glick, ME | 1 |
| Vella, S | 1 |
| Chang, HE | 1 |
| Smart, T | 2 |
| Baker, R | 1 |
| Gilden, D; Smart, T | 1 |
| Cheng, B | 1 |
| MacDougall, DS | 1 |
| Schouten, JT | 1 |
| Folkers, G | 1 |
| Mascolini, M | 1 |
| Feinberg, J | 1 |
| Adler-Storthz, K; Flaitz, CM; Hudnall, SD; Nichols, CM; Walling, DM | 1 |
| Conant, MA; Crooks, RJ; Crutchfield, LT; Gold, J; Murphy, RL; Schacker, TW | 1 |
| De Gruttola, V; Emery, VC; Feinberg, JE; Griffiths, P; Holland, F; Jacobson, MA; Nokta, MA; Pollard, RB | 1 |
10 review(s) available for valine and HIV Coinfection
| Article | Year |
|---|---|
Treating HCV in HIV 2013: on the cusp of change.
Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Coinfection; Drug Interactions; Drug Therapy, Combination; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Leucine; Oligopeptides; Proline; Pyrrolidines; Quinolines; Sofosbuvir; Thiazoles; Treatment Outcome; Uridine Monophosphate; Valine | 2014 |
Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir: A Review in Chronic HCV Genotype 1 Infection.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Resistance; Drug Resistance, Viral; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; HIV Infections; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Liver Transplantation; Macrocyclic Compounds; Proline; Ritonavir; Sulfonamides; Uracil; Valine | 2015 |
Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison.
Topics: Antiviral Agents; Carbamates; Clinical Trials, Phase III as Topic; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
Hepatitis C: efficacy and safety in real life.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Pyrrolidines; Ribavirin; Risk Factors; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2017 |
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance Abuse.
Topics: 2-Naphthylamine; Anilides; Anti-Retroviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Hepatitis C; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Proline; Protease Inhibitors; Ritonavir; Substance-Related Disorders; Sulfonamides; Uracil; Valine | 2017 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Challenges in genital herpes simplex virus management.
Topics: 2-Aminopurine; Acyclovir; Antibodies, Viral; Antiviral Agents; Condoms; Counseling; Famciclovir; Female; Global Health; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Male; Patient Education as Topic; Prevalence; Seroepidemiologic Studies; Valacyclovir; Valine; Virus Activation | 2002 |
Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
Topics: Acyclovir; Administration, Oral; Administration, Topical; Adult; Antiviral Agents; Child; Clinical Trials as Topic; Drug Resistance, Viral; Female; Herpes Genitalis; Herpes Labialis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Immunocompetence; Immunocompromised Host; Pregnancy; Pregnancy Complications, Infectious; Prodrugs; Valacyclovir; Valine | 2002 |
Progress in meeting today's demands in genital herpes: an overview of current management.
Topics: 2-Aminopurine; Acute Disease; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antibodies, Viral; Antiviral Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Famciclovir; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Immunocompetence; Patient Education as Topic; Prodrugs; Secondary Prevention; Treatment Outcome; Valacyclovir; Valine | 2002 |
Recent developments in the management of herpes simplex virus infection in HIV-infected persons.
Topics: Acyclovir; Antiviral Agents; Herpes Genitalis; Herpesvirus 2, Human; HIV; HIV Infections; Humans; Secondary Prevention; Valacyclovir; Valine | 2004 |
49 trial(s) available for valine and HIV Coinfection
| Article | Year |
|---|---|
Hepatitis C Virus (HCV) Direct-Acting Antiviral Therapy in Persons With Human Immunodeficiency Virus-HCV Genotype 1 Coinfection Resulting in High Rate of Sustained Virologic Response and Variable in Normalization of Soluble Markers of Immune Activation.
Topics: 2-Naphthylamine; Adult; Anilides; Anti-HIV Agents; Antiviral Agents; Biomarkers; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Immunologic Factors; Lactams, Macrocyclic; Liver Cirrhosis; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2020 |
Efficacy and safety of ravidasvir plus sofosbuvir in patients with chronic hepatitis C infection without cirrhosis or with compensated cirrhosis (STORM-C-1): interim analysis of a two-stage, open-label, multicentre, single arm, phase 2/3 trial.
Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Liver Cirrhosis; Malaysia; Male; Middle Aged; RNA, Viral; Safety; Sofosbuvir; Sustained Virologic Response; Thailand; Treatment Outcome; Valine; Viral Nonstructural Proteins | 2021 |
Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
Topics: Adult; Antiviral Agents; Benzimidazoles; Carbamates; Coinfection; Drug Therapy, Combination; Female; Fluorenes; Hemophilia A; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Interferons; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; RNA, Viral; Sofosbuvir; Valine; Viral Load | 2017 |
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practice.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine | 2018 |
High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
Topics: Acyclovir; Adult; Antiviral Agents; Coinfection; Cross-Over Studies; Cytomegalovirus; DNA, Viral; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; Patient Compliance; RNA, Viral; Valacyclovir; Valine; Viral Load; Virus Shedding | 2013 |
A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Topics: Acyclovir; Adult; Anti-Retroviral Agents; Antiviral Agents; C-Reactive Protein; CD8-Positive T-Lymphocytes; Coinfection; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Intercellular Adhesion Molecule-1; Interleukin-6; Lymphocyte Subsets; Male; Middle Aged; Placebos; Treatment Outcome; Valacyclovir; Valine | 2013 |
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Pyrrolidines; Ritonavir; Tenofovir; Valine; Viral Nonstructural Proteins; Young Adult | 2013 |
The effect of valacyclovir on HIV and HSV-2 in HIV-infected persons on antiretroviral therapy with previously unrecognised HSV-2.
Topics: Acyclovir; Adult; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; DNA, Viral; Double-Blind Method; Enzyme-Linked Immunosorbent Assay; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load | 2015 |
Valacyclovir Decreases Plasma HIV-1 RNA in HSV-2 Seronegative Individuals: A Randomized Placebo-Controlled Crossover Trial.
Topics: Acyclovir; Adult; Anti-HIV Agents; Cross-Over Studies; Female; HIV Infections; HIV-1; Humans; Male; Placebos; Plasma; RNA, Viral; Valacyclovir; Valine; Viral Load; Virus Replication; Young Adult | 2015 |
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH Study.
Topics: Antiviral Agents; Carbamates; Coinfection; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Treatment Outcome; Valine | 2015 |
[In Process Citation].
Topics: Anti-HIV Agents; Antiviral Agents; Carbamates; Cost Savings; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Pyrrolidines; Sofosbuvir; Valine; Viral Load | 2015 |
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
Topics: Adult; Aged; Anti-Retroviral Agents; Antiviral Agents; Carbamates; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; RNA, Viral; Sofosbuvir; Uridine Monophosphate; Valine; Viral Load | 2015 |
Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors.
Topics: 2-Naphthylamine; Adolescent; Adult; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Healthy Volunteers; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Ritonavir; Sulfonamides; Uracil; Valine; Young Adult | 2016 |
[In HIV-HCV co-infection check for drug interactions].
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Carbamates; Compassionate Use Trials; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
Drug-Drug Interaction between the Direct-Acting Antiviral Regimen of Ombitasvir-Paritaprevir-Ritonavir plus Dasabuvir and the HIV Antiretroviral Agent Dolutegravir or Abacavir plus Lamivudine.
Topics: 2-Naphthylamine; Adult; Anilides; Anti-HIV Agents; Anti-Retroviral Agents; Carbamates; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Interactions; Female; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lactams, Macrocyclic; Lamivudine; Macrocyclic Compounds; Male; Middle Aged; Oxazines; Piperazines; Proline; Pyridones; Ritonavir; Sulfonamides; Uracil; Valine | 2016 |
Daclatasvir 30 mg/day is the correct dose for patients taking atazanavir/cobicistat.
Topics: Adult; Anti-HIV Agents; Atazanavir Sulfate; Carbamates; Cobicistat; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Female; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Pyrrolidines; Ritonavir; Valine; Young Adult | 2017 |
Herpes Simplex Virus Suppressive Therapy in Herpes Simplex Virus-2/Human Immunodeficiency Virus-1 Coinfected Women Is Associated With Reduced Systemic CXCL10 But Not Genital Cytokines.
Topics: Acyclovir; Adult; Antiviral Agents; Chemokine CXCL10; Coinfection; Cross-Over Studies; Cytokines; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Middle Aged; Reproductive Tract Infections; Valacyclovir; Valine; Viral Load; Young Adult | 2016 |
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Pyrrolidines; Recombinant Proteins; Ribavirin; Treatment Outcome; Valine; Young Adult | 2017 |
Safety and Efficacy of Pegylated Interferon Lambda, Ribavirin, and Daclatasvir in HCV and HIV-Coinfected Patients.
Topics: Adult; Aged; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Interferons; Male; Middle Aged; Pyrrolidines; Ribavirin; Treatment Outcome; Valine; Viral Load | 2017 |
Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial.
Topics: Acyclovir; Adult; Antiviral Agents; Cross-Over Studies; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Middle Aged; Valacyclovir; Valine; Virus Replication | 2008 |
HSV suppression reduces seminal HIV-1 levels in HIV-1/HSV-2 co-infected men who have sex with men.
Topics: Acyclovir; Adult; Antiviral Agents; CD4 Lymphocyte Count; Cross-Over Studies; Double-Blind Method; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Middle Aged; RNA, Viral; Semen; Valacyclovir; Valine; Viral Load; Young Adult | 2009 |
Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial.
Topics: Acyclovir; Antiviral Agents; Clinical Protocols; Disease Progression; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Valacyclovir; Valine; Viral Load | 2010 |
High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a randomized, crossover trial.
Topics: Acyclovir; Adult; Antiviral Agents; Coinfection; Cross-Over Studies; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; RNA, Viral; Valacyclovir; Valine; Viral Load; Young Adult | 2011 |
Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: a randomized trial.
Topics: Acyclovir; Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Infectious Disease Transmission, Vertical; Kenya; Milk, Human; Nevirapine; Placebos; Plasma; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load; Young Adult; Zidovudine | 2012 |
Infant safety during and after maternal valacyclovir therapy in conjunction with antiretroviral HIV-1 prophylaxis in a randomized clinical trial.
Topics: Acyclovir; Adult; Anti-HIV Agents; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Mothers; Postpartum Period; Pregnancy; Prenatal Exposure Delayed Effects; Time Factors; Valacyclovir; Valine; Young Adult | 2012 |
Effects of valacyclovir on markers of disease progression in postpartum women co-infected with HIV-1 and herpes simplex virus-2.
Topics: Acyclovir; Antiviral Agents; Biomarkers; CD4 Antigens; Disease Progression; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Linear Models; Nevirapine; Postpartum Period; Pregnancy; RNA, Viral; Valacyclovir; Valine; Zidovudine | 2012 |
Short communication: T cell activation in HIV-1/herpes simplex virus-2-coinfected Kenyan women receiving valacyclovir.
Topics: Acyclovir; Adult; Antiviral Agents; Coinfection; Double-Blind Method; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Kenya; Lymphocyte Activation; Pregnancy; Pregnancy Complications, Infectious; Simplexvirus; T-Lymphocytes; Valacyclovir; Valine; Young Adult | 2013 |
Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir.
Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Drug Resistance, Viral; Herpesvirus 4, Human; HIV Infections; Humans; Leukoplakia, Hairy; Middle Aged; Mouth Mucosa; Treatment Outcome; Valacyclovir; Valine; Viral Proteins; Virus Replication | 2003 |
Health-related quality of life predicts survival, cytomegalovirus disease, and study retention in clinical trial participants with advanced HIV disease.
Topics: Acute Disease; Acyclovir; Adult; Age Factors; Anti-HIV Agents; Cytomegalovirus Infections; Double-Blind Method; Health Status; HIV Infections; Humans; Middle Aged; Patient Dropouts; Predictive Value of Tests; Proportional Hazards Models; Psychiatric Status Rating Scales; Quality of Life; Racial Groups; Sex Factors; Survival Rate; Valacyclovir; Valine | 2003 |
Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
Topics: Acyclovir; Adult; Antiviral Agents; Female; Herpes Genitalis; HIV Infections; HIV-1; Humans; Male; Middle Aged; Proportional Hazards Models; Secondary Prevention; Simplexvirus; Valacyclovir; Valine | 2003 |
Effect of Epstein-Barr virus replication on Langerhans cells in pathogenesis of oral hairy leukoplakia.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cell Count; Herpesvirus 4, Human; HIV Infections; Humans; Langerhans Cells; Leukoplakia, Hairy; Male; Middle Aged; Mouth; Valacyclovir; Valine; Virus Replication | 2004 |
Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
Topics: Acyclovir; Administration, Oral; Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Prodrugs; Secondary Prevention; Valacyclovir; Valine | 2004 |
Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial.
Topics: Acyclovir; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; DNA, Viral; Double-Blind Method; Female; Genitalia, Female; Herpes Genitalis; HIV Infections; HIV-1; Humans; Middle Aged; RNA, Viral; Ulcer; Valacyclovir; Valine; Viral Load | 2006 |
Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cervix Uteri; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; RNA, Viral; Valacyclovir; Valine; Viral Load; Virus Replication; Virus Shedding | 2007 |
Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cross-Over Studies; DNA, Viral; Double-Blind Method; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Homosexuality, Male; Humans; Male; Polymerase Chain Reaction; Rectum; RNA, Viral; Treatment Outcome; Valacyclovir; Valine; Viral Load | 2007 |
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Ritonavir; RNA, Viral; Thiazoles; Treatment Outcome; Valine | 1995 |
A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.
Topics: Adult; Antiviral Agents; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Ritonavir; RNA, Viral; Thiazoles; Treatment Outcome; Valine | 1995 |
Safety, pharmacokinetics, and antiviral activity of A77003, a C2 symmetry-based human immunodeficiency virus protease inhibitor.
Topics: Adolescent; Adult; Aged; CD4 Lymphocyte Count; Dose-Response Relationship, Drug; Female; HIV Core Protein p24; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Methylurea Compounds; Middle Aged; Pyridines; RNA, Viral; Valine | 1995 |
Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.
Topics: Acyclovir; Adult; Antiviral Agents; Chromatography, High Pressure Liquid; Female; Half-Life; Hemoglobins; HIV Antibodies; HIV Infections; Humans; Male; Middle Aged; Valacyclovir; Valine | 1994 |
Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir.
Topics: ADP-ribosyl Cyclase; ADP-ribosyl Cyclase 1; Antigens, CD; Antigens, Differentiation; Antiviral Agents; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Double-Blind Method; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Immune System; Leukocyte Common Antigens; Lymphocyte Activation; Membrane Glycoproteins; N-Glycosyl Hydrolases; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia | 1996 |
In vitro antiviral activity of 141W94 (VX-478) in combination with other antiretroviral agents.
Topics: Carbamates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Furans; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine | 1996 |
Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus (HIV) disease in a cytomegalovirus prophylaxis trial (ACTG 204).
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Double-Blind Method; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Male; Middle Aged; Prodrugs; Prospective Studies; Purpura, Thrombotic Thrombocytopenic; Risk Factors; Valacyclovir; Valine | 1997 |
Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; HIV Infections; Humans; Multivariate Analysis; Polymerase Chain Reaction; Prodrugs; Risk Factors; Survival Rate; Time Factors; Valacyclovir; Valine; Virus Replication | 1999 |
Treatment for primary infection.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cohort Studies; Controlled Clinical Trials as Topic; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Placebos; Pyridines; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Abbott laboratories files New Drug Application for ritonavir.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Double-Blind Method; Drugs, Investigational; HIV Infections; HIV Protease Inhibitors; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Ritonavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Protease inhibitors: ritonavir and saquinavir combination trial recruiting--seven U.S., Canada sites incl. San Francisco.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Matching up ritonavir with saquinavir.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Valaciclovir versus aciclovir for herpes simplex virus infection in HIV-infected individuals: two randomized trials.
Topics: Acyclovir; Adult; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Confidence Intervals; Double-Blind Method; Drug Administration Schedule; Female; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Recurrence; Simplexvirus; Treatment Outcome; Valacyclovir; Valine | 2002 |
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Case-Control Studies; Cytomegalovirus; Cytomegalovirus Infections; HIV Infections; Humans; Male; Multivariate Analysis; Polymerase Chain Reaction; Predictive Value of Tests; Risk Factors; Valacyclovir; Valine | 2002 |
117 other study(ies) available for valine and HIV Coinfection
| Article | Year |
|---|---|
Association of Sofosbuvir and Daclatasvir Plasma Trough Concentrations with Patient-, Treatment-, and Disease-Related Factors Among HIV/HCV-Coinfected Persons.
Topics: Antiviral Agents; Area Under Curve; Carbamates; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pilot Projects; Prospective Studies; Pyrrolidines; Sofosbuvir; Valine | 2022 |
Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.
Topics: Aged; Animals; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzimidazoles; Caco-2 Cells; Carbamates; Drug Interactions; Female; Fluorenes; Hepatitis C; HIV Infections; Humans; Imidazoles; Intestines; Lopinavir; Male; Maraviroc; Middle Aged; Pyrrolidines; Rats; Rats, Wistar; Ritonavir; Saquinavir; Valine; Zidovudine | 2019 |
Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.
Topics: 2-Naphthylamine; Aged; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Ribavirin; Ritonavir; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine | 2019 |
Real-world evidence of the effectiveness of ombitasvir-paritaprevir/r ± dasabuvir ± ribavirin in patients monoinfected with chronic hepatitis C or coinfected with human immunodeficiency virus-1 in Spain.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Logistic Models; Macrocyclic Compounds; Male; Middle Aged; Multivariate Analysis; Proline; Ribavirin; Spain; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uracil; Valine | 2019 |
Sustained virologic response and changes in liver fibrosis parameters following 12-wk administration of generic sofosbuvir and daclatasvir in HIV/HCV-coinfected patients with HCV genotype 4 infection.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2020 |
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Italy; Male; Middle Aged; Pyrrolidines; Regression Analysis; Retrospective Studies; Ribavirin; Simeprevir; Sofosbuvir; Sustained Virologic Response; Valine | 2020 |
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study.
Topics: Anilides; Antiviral Agents; Benzimidazoles; Coinfection; Cyclopropanes; Female; Fluorenes; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Lactams, Macrocyclic; Male; Middle Aged; Proline; Ribavirin; Simeprevir; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine | 2021 |
Single-pill sofosbuvir and daclatasvir for treating hepatis C in patients co-infected with human immunodeficiency virus.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Imidazoles; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Impact of sofosbuvir and daclastavir on health-related quality of life in patients co-infected with hepatitis C and human immunodeficiency virus.
Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Indonesia; Male; Prospective Studies; Pyrrolidines; Quality of Life; Sofosbuvir; Treatment Outcome; Valine | 2021 |
Daclatasvir plasma concentration assessment in HIV-HCV-coinfected real-life patients.
Topics: Antiviral Agents; Carbamates; Coinfection; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Pyrrolidines; Treatment Outcome; Valine; Viral Load | 2017 |
Chronic penile ulcer as the first manifestation of HIV infection.
Topics: Acyclovir; Anti-HIV Agents; Antiviral Agents; Chronic Disease; HIV Infections; HIV-1; Humans; Male; Penile Diseases; Skin Ulcer; Valacyclovir; Valine; Young Adult | 2017 |
Plasma trough concentrations of antiretrovirals in HIV-infected persons treated with direct-acting antiviral agents for hepatitis C in the real world.
Topics: 2-Naphthylamine; Anilides; Anti-Retroviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Proline; Prospective Studies; Ritonavir; Sofosbuvir; Sulfonamides; Treatment Outcome; Uracil; Valine | 2018 |
Remarkable plasma HIV RNA decrease by ombitasvir/paritaprevir/ritonavir in an HIV-HCV coinfection case.
Topics: Adult; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Plasma; Proline; Ritonavir; RNA, Viral; Sulfonamides; Valine; Viral Load | 2018 |
UPLC-MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patients.
Topics: Antiviral Agents; Carbamates; Chromatography, High Pressure Liquid; Coinfection; Hepatitis C; HIV Infections; Humans; Imidazoles; Limit of Detection; Linear Models; Pyrrolidines; Reproducibility of Results; Sofosbuvir; Tandem Mass Spectrometry; Valine | 2018 |
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Clinical Trials as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Observational Studies as Topic; Proline; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2019 |
Metabolites predict cardiovascular disease events in persons living with HIV: a pilot case-control study.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Carnitine; Female; Glutamine; HIV Infections; Humans; Male; Metabolome; Middle Aged; Valine | 2018 |
Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.
Topics: Adult; AIDS-Associated Nephropathy; Amino Acid Substitution; Catechol O-Methyltransferase; Female; Genetic Predisposition to Disease; Genotype; Genotyping Techniques; HIV Infections; Humans; Male; Methionine; Middle Aged; Neuralgia; Polymorphism, Single Nucleotide; Prospective Studies; United States; Valine | 2019 |
Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
Topics: Adult; Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Imidazoles; Interferons; Isoquinolines; Male; Middle Aged; Pyrrolidines; Retrospective Studies; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Valine | 2019 |
Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort.
Topics: Aged; Anemia; Antiviral Agents; Carbamates; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Tacrolimus; Valine | 2019 |
Molecular Determinants of Epistasis in HIV-1 Protease: Elucidating the Interdependence of L89V and L90M Mutations in Resistance.
Topics: Amino Acid Substitution; Catalytic Domain; Crystallography, X-Ray; Drug Resistance, Viral; Epistasis, Genetic; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Leucine; Methionine; Models, Molecular; Molecular Dynamics Simulation; Mutation, Missense; Protein Binding; Protein Denaturation; Valine | 2019 |
Use of agent-based simulations to design and interpret HIV clinical trials.
Topics: Acyclovir; Anti-HIV Agents; Circumcision, Male; Clinical Trials as Topic; Computer Simulation; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Male; Models, Theoretical; Monte Carlo Method; Research Design; Treatment Outcome; Valacyclovir; Valine | 2014 |
HIV-hepatitis C co-infection.
Topics: Antiviral Agents; Carbamates; Coinfection; Hepatitis C; HIV Infections; Humans; Imidazoles; Pyrrolidines; Randomized Controlled Trials as Topic; Sofosbuvir; Treatment Outcome; Uridine Monophosphate; Valine | 2015 |
Suspected pharmacokinetic interaction between raltegravir and the 3D regimen of ombitasvir, dasabuvir and paritaprevir/ritonavir in an HIV-HCV liver transplant recipient.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; HIV Infections; Humans; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Raltegravir Potassium; Ritonavir; Sulfonamides; Uracil; Valine | 2016 |
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir.
Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Interferon-alpha; Isoquinolines; Liver; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Pyrrolidines; Raltegravir Potassium; Recombinant Proteins; Ribavirin; Sulfonamides; Valine | 2015 |
Paritaprevir/ritonavir, ombitasvir, and dasabuvir for treatment of recurrent hepatitis C virus infection in the human immunodeficiency virus coinfected liver transplant recipient.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Therapy, Combination; Genotype; Graft Survival; Hepacivirus; Hepatitis C; HIV Infections; Humans; Immunosuppressive Agents; Lactams, Macrocyclic; Liver Transplantation; Macrocyclic Compounds; Male; Middle Aged; Proline; Recurrence; Ritonavir; RNA, Viral; Sulfonamides; Treatment Outcome; Uracil; Valine | 2016 |
Paritaprevir/ritonavir/ombitasvir and dasabuvir for the treatment of chronic hepatitis C virus infection.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Liver Cirrhosis; Macrocyclic Compounds; Proline; Ribavirin; Ritonavir; Sulfonamides; Uracil; Valine | 2015 |
Interferon-free treatment with sofosbuvir/daclatasvir achieves sustained virologic response in 100% of HIV/hepatitis C virus-coinfected patients with advanced liver disease.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Retrospective Studies; Sofosbuvir; Treatment Outcome; Valine | 2016 |
Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Atazanavir Sulfate; Carbamates; Coinfection; Cyclopropanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Lactams, Macrocyclic; Macrocyclic Compounds; Middle Aged; Proline; Ritonavir; Sulfonamides; Uracil; Valine | 2016 |
Severe Pulmonary Arterial Hypertension in Patients Treated for Hepatitis C With Sofosbuvir.
Topics: Antiviral Agents; Carbamates; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension, Portal; Hypertension, Pulmonary; Imidazoles; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
Treatment of chronic hepatitis C with direct acting antiviral agents in patients with haemophilia, end-stage liver disease and coinfected with HIV.
Topics: Adult; Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Coinfection; Drug Interactions; Hemophilia A; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Pyrrolidines; RNA, Viral; Sofosbuvir; Treatment Outcome; Valine; Viral Load | 2016 |
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; HIV Infections; HIV-1; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Sofosbuvir; Valine; Viral Load; Young Adult | 2016 |
Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.
Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; End Stage Liver Disease; Female; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Interferons; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Pyrrolidines; Recurrence; Ribavirin; Simeprevir; Sofosbuvir; Transplant Recipients; Treatment Outcome; Valine | 2016 |
Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients.
Topics: 2-Naphthylamine; Anilides; Carbamates; Coinfection; Cyclopropanes; Darunavir; Hepatitis C; HIV Infections; HIV-1; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Proline; Ritonavir; Sulfonamides; Uracil; Valine | 2016 |
Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir.
Topics: Anti-HIV Agents; Antiviral Agents; Area Under Curve; Carbamates; Coinfection; Darunavir; Diuretics; Drug Interactions; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Pyrrolidines; Renal Insufficiency; Ritonavir; Treatment Outcome; Valine | 2016 |
Direct Observed Therapy of Chronic Hepatitis C With Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility-a New Concept for Treatment of Patients With Borderline Compliance Receiving Opioid Substitution Therapy.
Topics: Adult; Antiviral Agents; Benzimidazoles; Carbamates; Coinfection; Directly Observed Therapy; Drug Therapy, Combination; Female; Fluorenes; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Male; Medication Adherence; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pyrrolidines; Severity of Illness Index; Sofosbuvir; Substance Abuse Treatment Centers; Valine | 2016 |
Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Carcinoma, Hepatocellular; Cost-Benefit Analysis; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Fluorenes; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferon-alpha; Lactams, Macrocyclic; Liver Cirrhosis; Liver Neoplasms; Macrocyclic Compounds; Markov Chains; Middle Aged; Polyethylene Glycols; Proline; Quality-Adjusted Life Years; Recombinant Proteins; Ribavirin; Ritonavir; Sofosbuvir; Sulfonamides; United States; Uracil; Valine | 2016 |
Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin.
Topics: Antiviral Agents; Carbamates; Coinfection; Drug Resistance, Viral; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Valine | 2016 |
Interferon-free regimens improve health-related quality of life and fatigue in HIV/HCV-coinfected patients with advanced liver disease: A retrospective study.
Topics: Antiviral Agents; Austria; Benzimidazoles; Carbamates; Coinfection; Fatigue; Female; Fluorenes; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Quality of Life; Retrospective Studies; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Valine | 2016 |
Successful treatment of three patients with human immunodeficiency virus and hepatitis C virus genotype 1b co-infection by daclatasvir plus asunaprevir.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Isoquinolines; Male; Middle Aged; Pyrrolidines; Sulfonamides; Valine | 2017 |
Daclatasvir plus sofosbuvir, with or without ribavirin, in real-world patients with HIV-HCV coinfection and advanced liver disease.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; HIV-1; Humans; Imidazoles; Liver Diseases; Liver Function Tests; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Treatment Outcome; Valine; Viral Load | 2017 |
Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong.
Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Coinfection; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Hong Kong; Lactams, Macrocyclic; Liver Cirrhosis; Liver Transplantation; Macrocyclic Compounds; Proline; Retrospective Studies; Ribavirin; Ritonavir; Sulfonamides; Time Factors; Treatment Outcome; Uracil; Valine | 2017 |
Effectiveness of All-Oral Antiviral Regimens in 996 Human Immunodeficiency Virus/Hepatitis C Virus Genotype 1-Coinfected Patients Treated in Routine Practice.
Topics: Administration, Oral; Aged; Anilides; Antiviral Agents; Benzimidazoles; Carbamates; Cohort Studies; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Practice Patterns, Physicians'; Proline; Registries; Ribavirin; Sofosbuvir; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Uridine Monophosphate; Valine; Veterans | 2017 |
Recalcitrant hypertrophic herpes genitalis in HIV-infected patient successfully treated with topical imiquimod.
Topics: Acyclovir; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antiviral Agents; Drug Therapy, Combination; Herpes Genitalis; HIV Infections; Humans; Hypertrophy; Imiquimod; Immunocompromised Host; Male; Middle Aged; Valacyclovir; Valine | 2017 |
Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort.
Topics: Adult; Aged; Antiviral Agents; Carbamates; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; France; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine | 2017 |
[Biliary and kidney lithiasis during treatment with daclatasvir/sofosbuvir/ribavirin and atazanavir/ritonavir + abacavir/lamivudine in an HIV/HCV genotype 4-infected patient: a case report.]
Topics: Adult; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; Biliary Tract Diseases; Carbamates; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Kidney Calculi; Lamivudine; Lithiasis; Male; Pyrrolidines; Ribavirin; Ritonavir; Sofosbuvir; Valine | 2017 |
3D-QSAR CoMFA/CoMSIA models based on theoretical active conformers of HOE/BAY-793 analogs derived from HIV-1 protease inhibitor complexes.
Topics: Crystallography, X-Ray; HIV Infections; HIV Protease; HIV Protease Inhibitors; HIV-1; Humans; Models, Molecular; Molecular Conformation; Protein Binding; Quantitative Structure-Activity Relationship; Valine | 2009 |
A missed point in deciphering the viral synergy between herpes simplex virus and HIV.
Topics: Acyclovir; Antiviral Agents; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Valacyclovir; Valine | 2009 |
Attachment and fusion inhibitors potently prevent dendritic cell-driven HIV infection.
Topics: Anti-HIV Agents; Cells, Cultured; Coculture Techniques; Dendritic Cells; HIV; HIV Envelope Protein gp41; HIV Fusion Inhibitors; HIV Infections; Humans; Peptide Fragments; Pyrazoles; T-Lymphocytes; Valine; Virus Replication | 2011 |
Herpes simplex virus type 2 suppressive therapy with acyclovir or valacyclovir does not select for specific HIV-1 resistance in HIV-1/HSV-2 dually infected persons.
Topics: Acyclovir; Adult; Amino Acid Substitution; Antiviral Agents; Botswana; Drug Resistance, Viral; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Kenya; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Peru; Point Mutation; Prospective Studies; Selection, Genetic; Sequence Analysis, DNA; United States; Valacyclovir; Valine | 2011 |
Time to refocus on HSV interventions for HIV prevention?
Topics: Acyclovir; Antiviral Agents; Female; Herpes Genitalis; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; RNA, Viral; Valacyclovir; Valine | 2011 |
Sustained release of the CCR5 inhibitors CMPD167 and maraviroc from vaginal rings in rhesus macaques.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; Biopsy; CCR5 Receptor Antagonists; Chromatography, High Pressure Liquid; Contraceptive Devices, Female; Cyclohexanes; Delayed-Action Preparations; Female; HIV Infections; HIV-1; Humans; Longitudinal Studies; Macaca mulatta; Maraviroc; Medroxyprogesterone Acetate; Pyrazoles; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tissue Distribution; Triazoles; Vagina; Valine; Virus Internalization | 2012 |
Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Topics: Acyclovir; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Disease Susceptibility; Fatal Outcome; Female; Herpes Zoster; HIV Infections; HIV-1; Humans; Immune Reconstitution Inflammatory Syndrome; Nigeria; Respiratory Tract Neoplasms; Sarcoma, Kaposi; Skin Neoplasms; Tuberculosis, Miliary; Valacyclovir; Valine; Viral Load; Viremia; Young Adult | 2011 |
Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor.
Topics: Adult; Antiviral Agents; Carbamates; Coinfection; Drug Resistance, Viral; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Imidazoles; Inhibitory Concentration 50; Male; Middle Aged; Mutation; Polymorphism, Single Nucleotide; Prevalence; Pyrrolidines; Valine; Viral Nonstructural Proteins | 2012 |
Acne keloidalis nuchae on herpes zoster scar in an HIV patient: isotopic response or not?
Topics: Acne Keloid; Acyclovir; Adult; Anti-HIV Agents; Antiviral Agents; Azithromycin; Black People; Cicatrix; Disease Susceptibility; Hair Follicle; Herpes Zoster; HIV Infections; Humans; Male; Neck; Sebaceous Glands; Triamcinolone Acetonide; Valacyclovir; Valine | 2012 |
Identification of a highly conserved valine-glycine-phenylalanine amino acid triplet required for HIV-1 Nef function.
Topics: Actin Cytoskeleton; Alleles; Amino Acid Motifs; Amino Acid Sequence; Conserved Sequence; Genes, MHC Class I; Glycine; HeLa Cells; HIV Infections; HIV-1; Host-Pathogen Interactions; Humans; Jurkat Cells; Lymphocytes; nef Gene Products, Human Immunodeficiency Virus; p21-Activated Kinases; Phenylalanine; Proto-Oncogene Proteins c-hck; Receptors, CXCR4; Sequence Deletion; Signal Transduction; Structure-Activity Relationship; trans-Golgi Network; Valine; Virus Replication | 2012 |
Response to valacyclovir in an HIV-infected girl with Epstein Barr infection.
Topics: Acyclovir; Alkynes; Antiretroviral Therapy, Highly Active; Antiviral Agents; Benzoxazines; Child; Cyclopropanes; Epstein-Barr Virus Infections; Female; HIV Infections; Humans; Lamivudine; Valacyclovir; Valine; Zidovudine | 2012 |
Novel mutations and SNPs identified in CCR2 using a new comprehensive denaturing gradient gel electrophoresis assay.
Topics: Amino Acid Substitution; Cohort Studies; Electrophoresis, Polyacrylamide Gel; Female; Genetic Predisposition to Disease; Genetic Variation; HIV Infections; HIV Seronegativity; HIV Seropositivity; HIV-1; Humans; Isoleucine; Male; Mutation; Nucleic Acid Denaturation; Polymorphism, Single Nucleotide; Receptors, CCR2; Receptors, Chemokine; Valine | 2002 |
Microbiology. Domino effects from battles against microbes.
Topics: Acyclovir; Adult; Antiviral Agents; Chickenpox; Chickenpox Vaccine; Controlled Clinical Trials as Topic; Female; Herpes Genitalis; Herpes Zoster; HIV Infections; Humans; Infant; Influenza Vaccines; Influenza, Human; Male; Public Health; Vaccination; Valacyclovir; Valine | 2002 |
Epitope-enhanced conserved HIV-1 peptide protects HLA-A2-transgenic mice against virus expressing HIV-1 antigen.
Topics: Adjuvants, Immunologic; Alanine; Amino Acid Substitution; Animals; Antigen Presentation; Cell Line; Chemokine CCL5; Conserved Sequence; Epitopes, T-Lymphocyte; Female; H-2 Antigens; HIV Antigens; HIV Infections; HIV Reverse Transcriptase; HIV-1; HLA-A2 Antigen; Humans; Injections, Intraperitoneal; Interferon-gamma; Leucine; Mice; Mice, Knockout; Mice, Transgenic; Oligopeptides; Protein Binding; T-Lymphocytes, Cytotoxic; Tyrosine; Valine | 2003 |
Use of antiviral drugs to prevent herpesvirus transmission.
Topics: Acyclovir; Antiviral Agents; Disease Transmission, Infectious; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Valacyclovir; Valine | 2004 |
Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia.
Topics: Acyclovir; Adult; Amino Acid Sequence; Antiviral Agents; DNA, Viral; Epithelium; Genotype; Herpesvirus 4, Human; HIV Infections; Humans; Leukocytes, Mononuclear; Leukoplakia, Hairy; Male; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Prospective Studies; Sequence Analysis, DNA; Tongue; Valacyclovir; Valine; Virus Activation; Virus Latency; Virus Replication | 2004 |
Expression of Epstein-Barr virus latent genes in oral epithelium: determinants of the pathogenesis of oral hairy leukoplakia.
Topics: Acyclovir; Biopsy; Epithelium; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Genes, Viral; Herpesvirus 4, Human; HIV Infections; Humans; Leukoplakia, Hairy; Mouth Mucosa; Retrospective Studies; RNA, Messenger; RNA, Viral; Transcription, Genetic; Valacyclovir; Valine; Viral Matrix Proteins; Viral Proteins; Virus Replication | 2004 |
Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses.
Topics: Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; Disease Models, Animal; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Macaca mulatta; Pyrazoles; Reassortant Viruses; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Valine; Viral Load; Virus Replication | 2004 |
Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.
Topics: Administration, Intravaginal; Animals; Anti-HIV Agents; CCR5 Receptor Antagonists; CD4 Antigens; Cell Fusion; Drug Therapy, Combination; Female; HIV; HIV Envelope Protein gp120; HIV Infections; Macaca mulatta; Membrane Fusion; Piperazines; Pyrazoles; Receptors, CCR5; Receptors, Virus; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Time Factors; Vagina; Valine | 2005 |
Drug firms donate compounds for anti-HIV gel.
Topics: Administration, Intravaginal; Africa; Animals; Anti-HIV Agents; Clinical Trials as Topic; Drug Industry; Drug Therapy, Combination; Female; Gels; HIV Infections; Humans; Male; Piperazines; Pyrazoles; Valine | 2005 |
An unusual vulval lesion in an HIV-infected woman.
Topics: Acyclovir; Adolescent; Anti-Retroviral Agents; Drug Resistance, Viral; Female; Herpes Simplex; HIV; HIV Infections; Humans; Pregnancy; Simplexvirus; Valacyclovir; Valine; Vulvar Diseases | 2007 |
Herpes treatment may limit HIV transmission and progression.
Topics: Acyclovir; Antiviral Agents; Disease Progression; Disease Transmission, Infectious; Female; Genitalia, Female; Herpes Simplex; HIV Infections; HIV-1; Humans; RNA, Viral; Time Factors; Valacyclovir; Valine; Viral Load | 2007 |
Entry inhibitor-based microbicides are active in vitro against HIV-1 isolates from multiple genetic subtypes.
Topics: Animals; Anti-Infective Agents, Local; CCR5 Receptor Antagonists; Drug Evaluation, Preclinical; Drug Interactions; Female; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; In Vitro Techniques; Male; Piperazines; Pyrazoles; Pyridines; Receptors, CXCR4; Sexual Behavior; Valine; Virus Internalization | 2007 |
The V118I mutation as a marker of advanced HIV infection and disease progression.
Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cross-Sectional Studies; Disease Progression; Drug Resistance, Multiple, Viral; Female; Follow-Up Studies; Genotype; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isoleucine; Logistic Models; Male; Mutation; Prognosis; Proportional Hazards Models; Reverse Transcriptase Inhibitors; Risk Assessment; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Failure; Valine | 2007 |
Evolution of resistance mutations during low-level viral replication in HIV-1-infected patients treated with zidovudine/lamivudine/abacavir as a first-line regimen.
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cohort Studies; Dideoxynucleosides; DNA, Viral; Drug Combinations; Drug Monitoring; Drug Resistance, Viral; Follow-Up Studies; Genotype; Germany; HIV Infections; HIV-1; Humans; Lamivudine; Methionine; Mutation; Reverse Transcriptase Inhibitors; Thymidine; Time Factors; Treatment Failure; Valine; Viral Load; Virus Replication; Zidovudine | 2007 |
HSV therapy and HIV-1 reduction.
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; RNA, Viral; Valacyclovir; Valine; Viral Load | 2007 |
HSV therapy and HIV-1 reduction.
Topics: Acyclovir; Antiviral Agents; Herpes Simplex; HIV Infections; HIV-1; Humans; RNA, Viral; Valacyclovir; Valine; Viral Load; Virus Replication | 2007 |
CCR5 blockade modulates inflammation and alloimmunity in primates.
Topics: Animals; Antibody Formation; Autoimmunity; CCR5 Receptor Antagonists; Cyclosporine; Disease Models, Animal; Graft Survival; Heart Transplantation; HIV Infections; Humans; Immunosuppressive Agents; Inflammation; Isoantibodies; Kidney Transplantation; Macaca fascicularis; Macrophages; Male; Pyrazoles; Stress, Physiological; T-Lymphocytes; Transplantation Tolerance; Transplantation, Homologous; Valine; Vascular Diseases | 2007 |
Update on HIV transmission and pathogenesis.
Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Genes, env; HIV; HIV Infections; HIV Protease Inhibitors; HIV-1; HLA-A Antigens; HLA-DR Antigens; HLA-DR Serological Subtypes; Humans; Macaca; Nevirapine; Pyridines; Reverse Transcriptase Inhibitors; Ritonavir; Simian Immunodeficiency Virus; Thiazoles; Time Factors; Valine; Virulence; Virus Latency; Virus Replication | 1995 |
A C2 symmetry-based HIV protease inhibitor, A77003, irreversibly inhibits infectivity of HIV-1 in vitro.
Topics: Antiviral Agents; Base Sequence; Cell Line; Gene Products, gag; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Molecular Sequence Data; Pyridines; RNA, Viral; Valine; Virion; Zidovudine | 1994 |
New HIV drugs approved after some deal-making.
Topics: HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine | 1996 |
Protease inhibitors show promise in HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; Valine | 1996 |
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.
Topics: Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Survival; Half-Life; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Kinetics; Models, Biological; Regression Analysis; Ritonavir; RNA, Viral; Thiazoles; Valine; Viremia; Virion; Virus Replication | 1996 |
New drugs for HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Zalcitabine | 1996 |
Japan's anti-AIDS drug arsenal slowly expands.
Topics: Antiviral Agents; Drug Approval; Drugs, Investigational; HIV Infections; Humans; Japan; Physicians; Protease Inhibitors; Public Opinion; Ritonavir; Thiazoles; United States; Valine; Zalcitabine | 1996 |
A new class of anti-HIV drugs debuts.
Topics: Drug Costs; Drug Resistance; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Ordered accumulation of mutations in HIV protease confers resistance to ritonavir.
Topics: Codon; Genotype; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Mutation; Phenotype; Ritonavir; Thiazoles; Valine | 1996 |
Ritonavir for advanced HIV infection.
Topics: Antiviral Agents; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles; Valine | 1996 |
Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.
Topics: Antiviral Agents; Cell Line; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Methylurea Compounds; Models, Biological; Monte Carlo Method; Pyridines; Valine; Zidovudine | 1996 |
Second protease inhibitor approved for HIV therapy.
Topics: Drug Approval; HIV Infections; HIV Protease Inhibitors; Ritonavir; Thiazoles; Valine | 1996 |
[For the first time a combination of 2 protease inhibitors investigated].
Topics: Antiviral Agents; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Transient renewal of thymopoiesis in HIV-infected human thymic implants following antiviral therapy.
Topics: Animals; Antigens, CD; Antigens, CD34; Antiviral Agents; CD4-Positive T-Lymphocytes; Didanosine; Drug Therapy, Combination; Flow Cytometry; Hematopoietic Stem Cells; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Lymphocyte Depletion; Methylurea Compounds; Mice; Mice, SCID; Polymerase Chain Reaction; Proviruses; Pyridines; T-Lymphocytes; Thymus Gland; Transplantation, Heterologous; Valine; Zidovudine | 1997 |
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
Topics: Anti-HIV Agents; Cohort Studies; Didanosine; Dideoxynucleosides; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Methionine; Point Mutation; Reverse Transcriptase Inhibitors; Stavudine; Valine; Zalcitabine; Zidovudine | 1998 |
HIV protease genotype and viral sensitivity to HIV protease inhibitors following saquinavir therapy.
Topics: Amino Acid Substitution; Carbamates; Clinical Trials as Topic; Databases, Factual; DNA, Viral; Furans; Genetic Linkage; Genotype; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Methionine; Nelfinavir; Phenotype; Polymerase Chain Reaction; Ritonavir; Saquinavir; Sulfonamides; Valine | 1998 |
Antiretroviral drugs: new agents, new combinations line up against HIV.
Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine | 1996 |
Chemokine control of HIV-1 infection.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemokine CCL2; Chemokine CXCL12; Chemokines, CXC; Dimerization; Disease Progression; HIV Infections; HIV-1; Humans; Isoleucine; Point Mutation; Receptors, CCR2; Receptors, CCR5; Receptors, Chemokine; Receptors, CXCR4; Receptors, Cytokine; Valine | 1999 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir | 1999 |
Closely related HIV-1 CRF01_AE variant among injecting drug users in northern Vietnam: evidence of HIV spread across the Vietnam-China border.
Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; China; Cloning, Molecular; Disease Outbreaks; Female; Genes, env; Genes, gag; Genome, Viral; HIV Infections; HIV-1; Humans; Male; Molecular Sequence Data; Risk Factors; Sexual Behavior; Substance Abuse, Intravenous; Valine; Vietnam | 2001 |
Prevalence and conditions of selection of E44D/A and V118I human immunodeficiency virus type 1 reverse transcriptase mutations in clinical practice.
Topics: Alanine; Amino Acid Substitution; Anti-HIV Agents; Aspartic Acid; Drug Resistance, Microbial; Gene Frequency; Glutamic Acid; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Isoleucine; Mutation; Valine | 2001 |
CTG studies yield results. AIDS Clinical Trials Group.
Topics: Acyclovir; Child; Clinical Trials as Topic; Cytomegalovirus Infections; Didanosine; Drug Therapy, Combination; Fluconazole; HIV Infections; Humans; Mycoses; Pneumonia, Pneumocystis; Valacyclovir; Valine; Zidovudine | 1995 |
Protease inhibitor trials moving to next phase.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Nelfinavir; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication | 1995 |
Abbott agrees to implement a compassionate use program for Ritonavir.
Topics: Acquired Immunodeficiency Syndrome; Altruism; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles; Valine | 1995 |
Update on HIV protease inhibitors.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Didanosine; Drug Design; Drug Therapy, Combination; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Phosphorylation; Pyridines; Quinolines; Ritonavir; Saquinavir; Substrate Specificity; Thiazoles; Valine; Zalcitabine; Zidovudine | 1995 |
Abbott protease inhibitor in combination: sustained viral load drop.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; RNA, Viral; Thiazoles; Valine | 1995 |
Ritonavir, saquinavir combination--& warning.
Topics: Dose-Response Relationship, Drug; Drug Resistance, Microbial; Half-Life; HIV Infections; Humans; Inactivation, Metabolic; Isoquinolines; Mutation; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1995 |
Conference looks at HIV drug resistance.
Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine | 1995 |
Ritonavir expanded access.
Topics: CD4 Lymphocyte Count; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Patient Selection; Ritonavir; Thiazoles; Valine | 1995 |
Kids studies.
Topics: Child; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; Valine | 1995 |
Highlights from the FDA antiviral drug advisory committee meetings, February 27-March 1, 1996.
Topics: Antiviral Agents; Device Approval; Drug Approval; Drug Therapy, Combination; Growth Hormone; HIV Infections; HIV Protease Inhibitors; Human Growth Hormone; Humans; Indinavir; Pyridines; Recombinant Proteins; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine; Virology | 1996 |
Three days that shook the world.
Topics: Antiviral Agents; Drug Approval; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine; Zidovudine | 1996 |
Ritonavir (Norvir).
Topics: HIV Infections; HIV Protease Inhibitors; Humans; Ritonavir; Thiazoles; Valine | 1996 |
Protease inhibitors-at-a-glance.
Topics: HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Update on protease inhibitors.
Topics: Antiviral Agents; Clinical Trials as Topic; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Placebos; Pyridines; Ritonavir; Stavudine; Thiazoles; Valine | 1996 |
Ritonavir: first to prolong survival.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine; Zalcitabine; Zidovudine | 1996 |
Ritonavir/saquinavir trial announced.
Topics: Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
Topics: Drug Approval; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine | 1996 |
Nipping HIV in the bud.
Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine | 1996 |
Two new protease inhibitors approved by FDA. Food and Drug Administration.
Topics: Drug Approval; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Pyridines; Ritonavir; Thiazoles; United States; United States Food and Drug Administration; Valine | 1996 |
Protease inhibitors.
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Pyridines; Quinolines; Ritonavir; Saquinavir; Thiazoles; Valine | 1996 |
Ritonavir plus saquinavir: two trials with different results.
Topics: CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Quinolines; Ritonavir; RNA, Viral; Saquinavir; Thiazoles; Valine | 1996 |
The status of CMV viral load testing.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; HIV Infections; Humans; Polymerase Chain Reaction; Prospective Studies; Valacyclovir; Valine; Viral Load; Viremia | 1996 |
Persistent productive Epstein-Barr virus replication in normal epithelial cells in vivo.
Topics: Acyclovir; Antiviral Agents; Biopsy; DNA-Binding Proteins; Epithelial Cells; Epstein-Barr Virus Infections; Herpesvirus 4, Human; HIV Infections; Humans; Leukoplakia, Hairy; Tongue; Trans-Activators; Valacyclovir; Valine; Viral Proteins; Virus Replication | 2001 |